Changes during storage indicate problems
Rigorous studies are still needed to confirm whether these peptides deliver consistent results in humans
The primary concern with hepatic impairment is a potential change in exposure to a drug that is extensively cleared by hepatic metabolism or biliary excretion via the liver, that could impact on the pharmacodynamic action or lead to adverse effects [19]
Evidence-based : Ensuring clinicians understand the difference between serum B12 levels and clinically active B12 stores, and other suitable tests to determine deficiency as well as symptom resolution with sufficiently frequent treatment
Athletes assume responsibility for supplement use, and WADA recommends using reputable third-party certification programs if athletes choose to use dietary supplements
Jouyban, A., Khoubnasabjafari, M